Top Anti Cancer Imported Medicine Drugs in India - Pharma Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Keytruda / Keytruda Qlex (Pembrolizumab) Medicine in India

Keytruda / Keytruda Qlex (Pembrolizumab)

Medicine name : Keytruda / Keytruda Qlex

Generic name : Pembrolizumab

Manufactured By : Merck & Co., Inc.

Indications : Treatment of adults and paediatric patients with unresectable or metastatic tumour mutational burden-high (TMB-H ≥13 mutations per megabase) solid tumours that have progressed following prior treatment and have no satisfactory alternative treatment option

Medicine Description : An immunotherapy for adults and eligible paediatric patients with unresectable or metastatic TMB-H solid tumours following prior treatment. Keytruda (Pembrolizumab) blocks the PD-1 protein, helping the immune system recognise and attack cancer cells.

Product Introduction

Keytruda / Keytruda Qlex (Pembrolizumab) are immunotherapy medicines used to treat various types of cancer. They are indicated for adults and paediatric patients with unresectable or metastatic tumour mutational burden-high (TMB-H) solid tumours, defined as 13 or more mutations per megabase (mut/Mb), when the cancer has progressed after previous treatment and no satisfactory alternative treatment options are available. Patient eligibility is determined using an FDA-authorised test.

Both formulations contain pembrolizumab, a programmed death receptor-1 (PD-1) blocker that helps the immune system recognise and attack cancer cells. Keytruda is administered through intravenous infusion, while Keytruda Qlex is given as a subcutaneous injection and also contains berahyaluronidase alfa-pmph, which facilitates administration under the skin.

Common side effects may include fatigue, muscle and joint pain, itching, diarrhoea, nausea, decreased appetite, rash, fever, cough and abdominal pain. Serious side effects can include immune-mediated inflammation affecting the lungs, liver, kidneys, intestines and other organs. Regular medical monitoring is important, and patients should promptly report new or worsening symptoms.

Uses Of Keytruda / Keytruda Qlex (Pembrolizumab)

Treatment of TMB-H Solid Tumours

Benefits Of Keytruda / Keytruda Qlex

Used to treat adults and children with unresectable or metastatic tumour mutational burden-high (TMB-H) solid tumours, defined as 13 or more mutations per megabase (mut/Mb). It is prescribed when the cancer has progressed after previous treatment and no satisfactory alternative treatment options are available. Patient eligibility is determined using an FDA-authorised test.

Side Effects Of Keytruda / Keytruda Qlex (Pembrolizumab)

Some patients may experience side effects during treatment with Keytruda / Keytruda Qlex (Pembrolizumab). Their severity can vary depending on the patient's health, cancer type and whether the medicine is used alone or with other treatments.

Common Side Effects of Keytruda / Keytruda Qlex (Pembrolizumab)

  • Fatigue
  • Muscle and joint pain
  • Skin rash
  • Diarrhoea
  • Fever
  • Cough
  • Decreased appetite
  • Itching
  • Nausea
  • Abdominal pain
How To Use Keytruda / Keytruda Qlex

Keytruda is administered as an intravenous infusion by a qualified healthcare professional, usually over 30 minutes every 3 or 6 weeks, depending on the prescribed treatment schedule. Keytruda Qlex is administered as a subcutaneous injection into the abdomen or thigh. It is generally given every 3 weeks over 1 minute or every 6 weeks over 2 minutes. The dosage and treatment duration depend on the cancer type, patient's condition and medical response.

How Keytruda / Keytruda Qlex (Pembrolizumab) Works

Pembrolizumab works by blocking the programmed death receptor-1 (PD-1) pathway, which cancer cells can use to avoid immune-system detection. By blocking this pathway, it helps activate the body's T cells to recognise and attack cancer cells. In Keytruda Qlex, berahyaluronidase alfa-pmph helps pembrolizumab spread and absorb under the skin, allowing subcutaneous administration.

Storage Conditions
  • Store unopened vials in a refrigerator at 2°C to 8°C (36°F to 46°F).
  • Keep vials in their original carton to protect them from light.
  • Do not freeze or shake the vials.
  • For Keytruda Qlex, use the prepared syringe immediately whenever possible. If necessary, it may be stored at 20°C to 25°C for up to 8 hours or refrigerated at 2°C to 8°C for up to 96 hours, protected from light.
Safety Advice

AlcoholAlcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment. Avoid excessive alcohol consumption, especially if you experience side effects.

PregnancyPregnancy CONSULT YOUR DOCTOR

May cause fetal harm. Confirm pregnancy status before treatment and use effective contraception during treatment and for 4 months after the last dose.

BreastfeedingBreastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment or for 4 months after the last dose, due to the potential risk of serious adverse reactions in the infant.

DrivingDriving CONSULT YOUR DOCTOR

Avoid driving if you experience fatigue, dizziness, weakness or other symptoms that may affect alertness.

KidneyKidney CAUTION

Inform your doctor about existing kidney problems. Regular monitoring of kidney function is important because immune-mediated kidney inflammation may occur.

LiverLiver CAUTION

Inform your doctor about any liver disease. Regular liver-function tests are important because treatment may cause immune-mediated hepatitis.

Quick Tips
  • Receive Keytruda or Keytruda Qlex only under qualified medical supervision.
  • Follow the prescribed treatment schedule and attend all appointments.
  • Inform your doctor about all medicines and supplements you are taking.
  • Report fever, persistent diarrhoea, breathing difficulties or unusual symptoms promptly.
  • Attend regular blood tests and medical check-ups to monitor treatment response and side effects.
  • Read More About - Keytruda / Keytruda Qlex (Pembrolizumab) from Pharma Five.
About Pharma Five

Pharma Five assists patients seeking Keytruda / Keytruda Qlex (Pembrolizumab) by facilitating the import of limited quantities for personal medical use, subject to applicable regulations. Depending on the requirements, Form 12A, a valid prescription from a Registered Medical Practitioner (RMP) and supporting documents may be required.

Backed by more than 20 years of pharmaceutical industry experience, Pharma Five offers specialised medicine consultancy and import facilitation for patients requiring Keytruda / Keytruda Qlex (Pembrolizumab). The team provides guidance on the necessary documentation and helps patients navigate applicable medicine import procedures. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

References
  1. https://go.drugbank.com/drugs/DB09037
  2. https://dailymed.awsprod.nlm.nih.gov/dailymed/drugInfo.cfm?setid=097d166f-b73b-41d3-9b37-7653cd2a0c41
  3. https://www.fda.gov/drugs/cancer-approvals/fda-grants-traditional-approval-pembrolizumab-or-pembrolizumab-and-berahyaluronidase-alfa-pmph
Faq

General Question

Keytruda and Keytruda Qlex are immunotherapy medicines containing pembrolizumab. They are used to treat various cancers, including certain unresectable or metastatic TMB-H solid tumours when previous treatment has not worked and no satisfactory alternative is available.

Pembrolizumab blocks the PD-1 pathway, helping the immune system recognise and attack cancer cells. This allows immune cells, particularly T cells, to respond more effectively against cancer.

Keytruda is prescribed for eligible adults and paediatric patients with certain cancers, depending on the approved indication. Keytruda Qlex is prescribed for eligible adult patients. A cancer specialist determines suitability based on the diagnosis and treatment history.

Keytruda is administered through intravenous infusion, while Keytruda Qlex is given as a subcutaneous injection. Both must be administered by qualified healthcare professionals according to the prescribed dose and schedule.

Common side effects may include fatigue, muscle and joint pain, skin rash, itching, diarrhoea, nausea, decreased appetite, fever, cough and abdominal pain.

Yes. Pembrolizumab can cause serious immune-related reactions affecting organs such as the lungs, liver, kidneys, intestines and thyroid. Severe skin reactions and allergic reactions may also occur. Seek medical attention if unusual or worsening symptoms develop.

The treatment duration depends on the cancer type, prescribed regimen, treatment response and side effects. Your oncologist will decide how long treatment should continue.

Consult your doctor before consuming alcohol during treatment. Alcohol may worsen certain symptoms or complicate the management of treatment-related side effects.

Pembrolizumab may cause harm to an unborn baby. Women who can become pregnant should use effective contraception during treatment and for 4 months after the last dose.

Keytruda and Keytruda Qlex may interact with other treatments or medicines through their effects on the immune system. Inform your doctor about all prescription medicines, supplements and other treatments you are receiving.

If you miss a scheduled infusion or injection, contact your healthcare provider as soon as possible to arrange another appointment. Do not take an extra dose or change your treatment schedule yourself.

Keytruda and Keytruda Qlex are not oral medicines, so food does not directly affect their administration. Follow your doctor's dietary advice during cancer treatment.

Attend all scheduled appointments and laboratory tests. Inform your doctor about existing medical conditions and other medicines, and promptly report persistent diarrhoea, breathing difficulties, unusual fatigue, yellowing of the skin or other new symptoms.

Store unopened Keytruda and Keytruda Qlex vials in a refrigerator at 2°C to 8°C (36°F to 46°F), protected from light in their original cartons. Do not freeze or shake the vials.

Pharma Five provides medicine consultancy and import facilitation for patients seeking Keytruda / Keytruda Qlex (Pembrolizumab). Assistance with personal-use medicine imports is subject to applicable regulations, prescriptions and supporting documentation. Pharma Five assists in its procurement.

Timely Service
Doorstep Delivery
Hassle-Free Process
100% Genuine Sources